117 Hypertension awareness, treatment, and control in hypertensive CHD patients 5 REFERENCES 1. Cífková R, Lánská V, Bruthans J, Mayer O, Kotseva K, Wood D, et al. Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry. J Hypertens. 2019;37(10):2015–23. 2. Visseren FLJ, MacH F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337. 3. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA- Journal of the American Medical Association. 2013;310(9):959–68. 4. Antikainen RL, Moltchanov VA, Chukwuma C, Kuulasmaa KA, Marques-Vidal PM, Sans S, et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. European Journal of Cardiovascular Prevention & Rehabilitation. 2006;13(1):13–29. 5. Jankowski P, Kawecka-Jaszcz K, Bilo G, Pajak A. Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press. 2005;14(5):284–92. 6. Reiner Z, Sonicki Z, Tedeschi-Reiner E. Public perceptions of cardiovascular risk factors in Croatia: The PERCRO survey. Prev Med (Baltim). 2010;51(6):494–6. 7. Palafox B, McKee M, Balabanova D, Alhabib KF, Avezum A, Bahonar A, et al. Wealth and cardiovascular health: A cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016;15(1):15–7. 8. Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):1–12. 9. Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Rydén L, et al. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013. Glob Heart. 2017;12(4):315-322.e3. 10. Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824–35. 11. The World Bank. World Bank Country and Lending Groups. 2023. 12. Bruthans J, Mayer O, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, et al. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23(8):881–90. 13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. 14. Smedt D De, Backer T De, Petrovic M, Backer G De, Wood D, Kotseva K, et al. Chronic medication intake in patients with stable coronary heart disease across Europe : Evidence from the daily clinical practice . Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes ( EUROASPIRE IV ) Registry. Int J Cardiol. 2020;300:7–13. 15. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315–81. 16. RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA: RStudio, Inc.; 2016. 17. Tapela N, Collister J, Clifton L, Turnbull I, Rahimi K, Hunter DJ. Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK. Open Heart. 2021 Mar 11;8(1). 18. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in lowand middleincome countries: Prevalence, awareness and control. Int J Epidemiol. 2014;43(1):116–28. 19. Alm-Roijer C, Stagmo M, Udén G, Erhardt L. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. European Journal of Cardiovascular Nursing. 2004 Dec;3(4):321–30. 20. Karthik S, Tahir N, Thakur B, Nair U. Risk factor awareness and secondary prevention of coronary artery disease: Are we doing enough? In: Interactive Cardiovascular and Thoracic Surgery. 2006. p. 268–71. 21. Vynckier P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D. Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry. Int J Cardiol. 2022;352(December 2021):152–7. 22. Tchicaya A, Braun M, Lorentz N, Delagardelle C, Beissel J, Wagner DR. Social inequality in awareness of cardiovascular risk factors in patients undergoing coronary angiography. Eur J Prev Cardiol. 2013 Oct;20(5):872–9. 23. Mohd Azahar NMZ, Krishnapillai ADS, Zaini NH, Yusoff K. Risk perception of cardiovascular diseases among individuals with hypertension in rural Malaysia. Heart Asia. 2017 Jul;9(2):e010864.
RkJQdWJsaXNoZXIy MTk4NDMw